UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreWinter 2024/2025 Myeloma Magazine
The goal of Myeloma is to provide timely updates about progress in clinical treatment and research advances, as well as stories and information of general interest.
Read MagazineMyeloma Center: Looking Toward the Future: Myeloma Center Celebrates 35th Anniversary
The Myeloma Center, located in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), has firmly established itself as an international leader in myeloma treatment. From its beginnings in 1989, UAMS’ myeloma program is recognized for detailed patient care, groundbreaking research and pioneering advances in the management of myeloma…
News & Announcements
24-Year Myeloma Survivor Cites Positive Attitude as Key to Longevity
Jeff Williams maintains a basic approach to living with multiple myeloma. “Get as much exercise as possible,” he said. “I work about a mile from a YMCA. I stay in shape. It has to be a habit. If you go long enough, it will become a habit. Resistance training builds bone density.” Williams, 66, is…
Read more
UAMS Invests Fenghuang “Frank” Zhan, M.D., Ph.D., in Inaugural Barlogie Chair for Myeloma Research
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) College of Medicine invested Fenghuang “Frank” Zhan, M.D., Ph.D., a tenured professor of medicine and the research director of the UAMS Winthrop P. Rockefeller Cancer Institute’s Myeloma Center, in the Dr. Bart Barlogie Chair for Myeloma Research during a March 13 ceremony. Zhan is…
Read more
Behind the Scenes
Visanu Wanchai, Ph.D. Visanu Wanchai, Ph.D., is a postdoctoral fellow with the UAMS College of Medicine. He earned his doctorate in biomedical informatics from UAMS in 2020 and joined the Myeloma Center in 2022. His focus is developing leading-edge computational tools and employing high-performance computing techniques for single cell analysis to investigate key genes and…
Read more
Publications
Bispecific BCMA/CD24 CAR T cells control multiple myeloma growth Nature Communications January 2024 Primary authors: Fumou Sun, Ph.D.; Yan Cheng, Ph.D. Anti-multiple myeloma B cell maturation antigen (BCMA)-specific chimeric antigen receptor (CAR) T-cell therapies represent a promising treatment strategy with high response rates in myeloma. However, durable cures following anti-BCMA CAR T-cell treatment of myeloma…
Read moreWant to read more stories like these?